- EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.
The medical devices company is likely to stick to small- to mid- sized M&A unless it finds itself the target.
St. Jude shares deserve to be higher ahead of the merger with Abbott Labs. Here's why.